NT-PROBNP PREDICTS RECURRENCE AFTER CATHETER ABLATION IN A HYPERTENSIVE POPULATION UNDERGOING AGGRESSIVE BLOOD PRESSURE MANAGEMENT: A SUB-STUDY OF SMAC-AF
Abstract
Radiofrequency catheter ablation for atrial fibrillation (AF) has developed into a mainstay therapy. The recent Substrate Modification with Aggressive Blood Pressure Control (SMAC-AF) randomized controlled trial did not find that reducing blood pressure prior to ablation reduced recurrence of AF. There has been developing interest in NT-proBNP being a biomarker that could predict ablation success. We investigated the effect of baseline NT-proBNP...
Paper Details
Title
NT-PROBNP PREDICTS RECURRENCE AFTER CATHETER ABLATION IN A HYPERTENSIVE POPULATION UNDERGOING AGGRESSIVE BLOOD PRESSURE MANAGEMENT: A SUB-STUDY OF SMAC-AF
Published Date
Oct 1, 2019
Volume
35
Issue
10
Pages
S66 - S66
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History